October 4-5, 2018 | Boston, MA
Pre-Conference Workshop Days | October 2-3, 2018

  Save $500 On Your Attendance

Building on the success of 2017, the 2018 Clinical Biomarkers & World CDx Boston iteration will continue to cement the biomarker and translational development content at the heart of the meeting, enabling attendees to take a journey along the whole development continuum from exploratory biomarker, through clinical validation, past regulatory and reimbursement hurdles and into a globally adopted drug-Dx product.

For 2018 we have two overarching themes that underpin and flow through the whole meeting:

    1. Enhance the robust validation of next-generation predictive biomarker signatures to accelerate the development and approval of innovative targeted therapeutics
    2. Improving the uptake of high value precision medicines and diagnostic testing to progress the standard of care for patients worldwide

The four day meeting is split into two halves: pre-conference and main conference. Our pre-conference days will contain half-day workshop sessions, designed to take deep, interactive dives into a specific subject area. The main two day conference is separated into three streams covering translational development, clinical validation and implementation and drug-Dx commercialisation.

Click below to find out more about our biomarker and diagnostic sides to the event.